CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 101 filers reported holding CYTOKINETICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $19,850,000 | +131.5% | 1,633,726 | +74.9% | 0.00% | +100.0% |
| Q3 2016 | $8,574,000 | +2.4% | 934,027 | +5.9% | 0.00% | 0.0% |
| Q2 2016 | $8,370,000 | +33.7% | 881,984 | -0.7% | 0.00% | +100.0% |
| Q1 2016 | $6,260,000 | -34.9% | 887,957 | -3.4% | 0.00% | -50.0% |
| Q4 2015 | $9,618,000 | +61.8% | 919,488 | +3.5% | 0.00% | 0.0% |
| Q3 2015 | $5,943,000 | -1.6% | 888,300 | -1.2% | 0.00% | +100.0% |
| Q2 2015 | $6,041,000 | -5.8% | 898,910 | -4.9% | 0.00% | -50.0% |
| Q1 2015 | $6,411,000 | -15.2% | 945,528 | +0.1% | 0.00% | 0.0% |
| Q4 2014 | $7,563,000 | +163.2% | 944,173 | +15.7% | 0.00% | +100.0% |
| Q3 2014 | $2,873,000 | -28.7% | 816,242 | -3.2% | 0.00% | 0.0% |
| Q2 2014 | $4,030,000 | -51.8% | 843,197 | -4.1% | 0.00% | -50.0% |
| Q1 2014 | $8,357,000 | +77.1% | 879,689 | +21.2% | 0.00% | +100.0% |
| Q4 2013 | $4,718,000 | -16.6% | 725,888 | -2.9% | 0.00% | -50.0% |
| Q3 2013 | $5,657,000 | – | 747,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |